Microbix Biosystems Inc. · Toronto, ON Canada (Toronto: MBX)
| 115 Skyway Ave. | Phone: +1-416-234-1624 |
| Toronto, ON | Fax: +1-416-234-1626 |
| M9W 4Z4 | |
| Canada | 
Map This Company |
Microbix Biosystems Inc. Rankings
Company Description
Microbix makes biotherapeutic drugs, vaccines, and infectious disease diagnostics for multinational manufacturers. The company's pipeline includes leading generic drug candidate ThromboClear for the treatment of coronary artery thrombosis and the FDA-approved drug urokinase, used to treat pulmonary embolism. Microbix has also submitted patents for its Sperm Sexing Technology, which enables livestock producers to predetermine offspring gender prior to conception. In 2008 Microbix entered into an agreement with China to build one of the world's largest influenza manufacturing plants to produce flu vaccines.
Microbix Biosystems Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - Toronto: MBX Headquarters |
|---|---|
| Fiscal Year-End | September |
| 2011 Employees | 46 |
Executives
6 executives listed for Microbix Biosystems Inc.'s Toronto, ON location.